Senior insider sale
CLIMB BIO, INC. — senior position signals high conviction
$847.1K
150K shares
What this filing means
THOMAS STEPHEN BASIL plans to sell 150K shares of CLIMB BIO, INC. valued at approximately $847.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/25/2026ACC: 0001950047-26-001761
150K
Shares to sell
$847.1K
Approx. market value
50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Founders Shares
N/A
11/15/2023
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2023 | Founders Shares N/A | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10K
Market value
$58.1K
2/13/2026
—Completed
Units to sell
90K
Market value
$471.0K
2/12/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$318.0K
2/25/2026
Total
Units
150K
Value
$847.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/13/2026 | 10K | $58.1K | — | Completed |
2/12/2026 | 90K | $471.0K | — | Completed |
| Planned — Approximate Date | ||||
2/25/2026 | 50K | $318.0K | NASDAQ | Planned |
| Total | 150K | $847.1K | ||